These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29329660)

  • 1. Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: A machine learning and multi-variable modelling study.
    Abdollahi H; Mostafaei S; Cheraghi S; Shiri I; Rabi Mahdavi S; Kazemnejad A
    Phys Med; 2018 Jan; 45():192-197. PubMed ID: 29329660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N; Kaushal D; Patro SK; Pareek P; Dixit A; Soni K; Prakasan Nair N; Choudhury B; Goyal A
    Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
    Theunissen EA; Bosma SC; Zuur CL; Spijker R; van der Baan S; Dreschler WA; de Boer JP; Balm AJ; Rasch CR
    Head Neck; 2015 Feb; 37(2):281-92. PubMed ID: 24478269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
    Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S
    J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.
    Cheraghi S; Nikoofar P; Fadavi P; Bakhshandeh M; Khoie S; Gharehbagh EJ; Farahani S; Mohebbi A; Vasheghani M; Zare M; Nikoofar A; Mahdavi SR
    Med Oncol; 2015 Jul; 32(7):200. PubMed ID: 26071124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics.
    Jin X; Zheng X; Chen D; Jin J; Zhu G; Deng X; Han C; Gong C; Zhou Y; Liu C; Xie C
    Eur Radiol; 2019 Nov; 29(11):6080-6088. PubMed ID: 31028447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
    Espenel S; Garcia MA; Guy JB; Vallard A; Ben Mrad M; Langrand-Escure J; El Meddeb Hamrouni A; Trone JC; Xia Y; Rancoule C; Magné N
    Cancer Radiother; 2017 Feb; 21(1):77-83. PubMed ID: 28189351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning.
    Kawahara D; Murakami Y; Tani S; Nagata Y
    Br J Radiol; 2021 Aug; 94(1124):20210525. PubMed ID: 34235955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
    Theunissen EA; Zuur CL; Józwiak K; Lopez-Yurda M; Hauptmann M; Rasch CR; van der Baan S; de Boer JP; Dreschler WA; Balm AJ
    JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):810-5. PubMed ID: 26291150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
    Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm.
    Mostafaei S; Abdollahi H; Kazempour Dehkordi S; Shiri I; Razzaghdoust A; Zoljalali Moghaddam SH; Saadipoor A; Koosha F; Cheraghi S; Mahdavi SR
    Radiol Med; 2020 Jan; 125(1):87-97. PubMed ID: 31552555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
    Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
    Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
    Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
    Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
    Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
    Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
    Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
    Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
    Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics based predictive modeling of rectal toxicity in prostate cancer patients undergoing radiotherapy: CT and MRI comparison.
    Hassaninejad H; Abdollahi H; Abedi I; Amouheidari A; Tavakoli MB
    Phys Eng Sci Med; 2023 Dec; 46(4):1353-1363. PubMed ID: 37556091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
    Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
    Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.